Monthly update: April 2025

Human zoonotic influenza vaccines:

• The French NITAG published its recommendations on the H5N1 zoonotic influenza, available in French here.

If other NITAGs are making recommendation on H5, please inform us as we are tracking these recommendations.

PCV:

• The French NITAG published its framework note in view of reviewing the the vaccination strategy against invasive pneumococcal infections in infants, children and adults. The note is available in French here.  

RSV:

• STIKO (German NITAG) extended the standard and indicated adult vaccination against RSV to include an mRNA vaccine, available here in German.

Polio:

• Sana's NITAG (North Yemen) recommended the use of nOPV2. 

Health economics for NITAGs:

• A new training module is available here on health economics. It is meant to be delivered in person but we are working on the online version.
• WHO EMRO organized a webinar on health economics and the recording is available here.

People who are immunocompromised:

• ATAGI (Australian NITAG), with the support of NCIRS, revised the section of the Australian Immunisation handbook dedicated to people who are immunocompromised. The revised section is available here.

Travel vaccination:

• STIKO along with the German Society for Tropical Medicine issued their recommendations on travel vaccination, available in German here.

ACIP:

• The presentation slides from the April 15-16 meeting are available here, including presentations on Mpox, Influenza, COVID-19 vaccines, HPV, CMV vaccines, Meningococcal Vaccines, RSV for adults and maternal/pediatrics and Chikungunya Vaccines. 

SAGE:

• The RSV Position Paper is expected to be published on 30 May 2025 - stay tune.

WHO: 

• WHO invites comments on the WHO Evidence Considerations for Vaccine Policy Development (ECVP) for Group B Streptococcal Vaccines Intended for Pregnant People.
  Deadline: 16 May 2025. Here is the link to submit a comment on the draft guidance. Please share within your professional networks.
• A New Report on Immunization Goal highlights need for redoubled efforts to reach 2030 global immunization targets. Read the full report here.

GNN: 

• With support from a dedicated working group, the GNN is developing the NITAG Online Learning Journey - a 12-week, self-paced course featuring weekly one-hour sessions with subject matter experts. A pilot is planned for the end of the year, so stay tuned if you're interested in joining the inaugural cohort.